Reduced Proteasomal Activity in Marrow Cells From Myelodysplastic Syndrome (MDS) Patients.

被引：0

作者：

Karabina, Stela ^{[1
]}

Thanopoulou, Eleni ^{[1
]}

Athanasiou, Sotirios D. ^{[2
]}

Symeonidis, Argiris ^{[3
]}

Zoumbos, Nicholas ^{[4
]}

机构：

[1] Univ Patras, Sch Med, Div Hematol, Dept Internal Med, Patras, Greece

[2] Univ Patras, Dept Chem, Biochem Lab, Patras, Greece

[3] Univ Patras, Sch Med, GR-26110 Patras, Greece

[4] Univ Patras, Rion, Greece

来源：

BLOOD | 2009年 / 114卷 / 22期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：706 / 707

页数：2

共 50 条

[41] Bone Marrow Stem Cells from Patients with Myelodysplastic Syndrome (MDS) Engraft and Migrate in-between the Humanized Niches in Immuno-Compromised Mouse Models [J].

Mian, Syed A. ;

Rouault-Pierre, Kevin ;

Smith, Alexander E. ;

Abarrategi, Ander ;

Coats, Thomas ;

McLornan, Donal ;

Mufti, Ghulam ;

Bonnet, Dominique .

BLOOD, 2017, 130

[42] Anti-erythroblast antibodies and defective apoptosis in bone marrow of early myelodysplastic syndrome patients. [J].

Zaninoni, A ;

Imperiali, FG ;

Fermo, E ;

Zanella, A ;

Barcellini, W .

BLOOD, 2004, 104 (11) :260B-260B

[43] The clinical significance or apoptosis in the marrow of patients with primary myelodysplastic syndromes (MDS) [J].

Kouraklis, A ;

Tsoplou, P ;

Symeonidis, A ;

Orphanos, V ;

Zoumbos, N .

BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 :263-263

[44] Three color analysis of apoptosis in each lineage progenitor cell during the differentiation in myelodysplastic syndrome (MDS) patients. [J].

Oyake, T ;

Ishida, Y ;

Ito, S ;

Murai, K ;

Ono, Y ;

Ito, T ;

Kuriya, S .

BLOOD, 1998, 92 (10) :254B-254B

[45] The Genetic and Morphologic Features of Myelodysplastic Syndrome (MDS) and Pre-MDS States in Patients with VEXAS Syndrome [J].

Ding, Yanna ;

Braylan, Raul ;

Dulau-Florea, Alina ;

Patel, Nisha ;

Maric, Irina ;

De Leon, Seila ;

Upadhyaya, Kalpana ;

Ferrada, Marcela ;

Groarke, Emma ;

Patel, Bhavisha ;

Beck, David ;

Grayson, Peter ;

Young, Neal ;

Calvo, Katherine .

LABORATORY INVESTIGATION, 2024, 104 (03) :S1396-S1397

[46] Depletion of lymphocytes increases the in vitro hemopoiesis in long term bone marrow cultures (LTBMC) from patients with myelodysplastic syndrome (MDS): Implications for the immunosuppressive therapy of MDS. [J].

Scheid, C ;

Baumann, I ;

Koref, MS ;

Swindell, R ;

Testa, NG ;

Stern, PL ;

Dexter, TM .

BLOOD, 1999, 94 (10) :390A-390A

[47] Apoptosis in bone marrow of myelodysplastic syndrome patients [J].

Bogdanovic, AD ;

Jankovic, GM ;

Colovic, MD ;

Trpinac, DP ;

Bumbasirevic, VZ .

BLOOD, 1996, 87 (07) :3064-3064

[48] Secondary myelodysplastic syndrome (MDS) in previously treated myeloma patients [J].

Boskovic, D ;

Marisavljevic, D ;

Radosevic, N ;

Elezovic, I ;

Mijovic, A ;

Tomin, D ;

Gotic, M .

BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) :356-356

[49] Lenalidomide effects on NK function in patients with myelodysplastic syndrome (MDS). [J].

Epling-Burnette, PK ;

Bai, FQ ;

Painter, JS ;

Djeu, JY ;

List, AF .

BLOOD, 2005, 106 (11) :959A-960A

[50] Bone marrow dendritic cells are reduced in patients with high-risk myelodysplastic syndromes [J].

Saft, Leonie ;

Bjorklund, Elisabet ;

Berg, Elisabeth ;

Hellstrom-Lindberg, Eva ;

Porwit, Anna .

LEUKEMIA RESEARCH, 2013, 37 (03) :266-273

← 1 2 3 4 5 →